spacer
spacer

PDBsum entry 4ucn

Go to PDB code: 
protein ligands links
Transferase PDB id
4ucn

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
411 a.a.
Ligands
JRB
MYA
Waters ×324
PDB id:
4ucn
Name: Transferase
Title: Crystal structure of leishmania major n-myristoyltransferase (nmt) with bound myristoyl-coa and a fragment
Structure: Glycylpeptide n-tetradecanoyltransferase. Chain: a. Fragment: residues 5-421. Engineered: yes
Source: Leishmania major. Organism_taxid: 5664. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.80Å     R-factor:   0.170     R-free:   0.200
Authors: D.A.Robinson,P.G.Wyatt
Key ref: D.A.Robinson and P.G.Wyatt (2015). Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase. Acta Crystallogr F Struct Biol Commun, 71, 586-593. PubMed id: 25945713 DOI: 10.1107/S2053230X15003040
Date:
04-Dec-14     Release date:   13-May-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q4Q5S8  (Q4Q5S8_LEIMA) -  Glycylpeptide N-tetradecanoyltransferase from Leishmania major
Seq:
Struc:
421 a.a.
411 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.3.1.97  - glycylpeptide N-tetradecanoyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: N-terminal glycyl-[protein] + tetradecanoyl-CoA = N-tetradecanoylglycyl- [protein] + CoA + H+
N-terminal glycyl-[protein]
+
tetradecanoyl-CoA
Bound ligand (Het Group name = MYA)
corresponds exactly
= N-tetradecanoylglycyl- [protein]
+ CoA
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1107/S2053230X15003040 Acta Crystallogr F Struct Biol Commun 71:586-593 (2015)
PubMed id: 25945713  
 
 
Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase.
D.A.Robinson, P.G.Wyatt.
 
  ABSTRACT  
 
Trypanosoma brucei N-myristoyltransferase (TbNMT) is an attractive therapeutic target for the treatment of human African trypanosomiasis. Pyrazole sulfonamide (DDD85646), a potent inhibitor of TbNMT, has been identified in previous studies; however, poor central nervous system exposure restricts its use to the haemolymphatic form (stage 1) of the disease. In order to identify new chemical matter, a fragment screen was carried out by ligand-observed NMR spectroscopy, identifying hits that occupy the DDD85646 binding site. Crystal structures of hits from this assay have been obtained in complex with the closely related NMT from Leishmania major, providing a structural starting point for the evolution of novel chemical matter.
 

 

spacer

spacer